Showing results (51-60 of 253) with videos related to

Sort By:
Pageof 26
The New England Journal of Medicine|June 6, 2008
Aliskiren combined with losartan in type 2 diabetes and nephropathyHans-Henrik Parving, Frederik Persson, Julia B Lewis, et al.
Diabetes Care|July 8, 2010
Vitamin D levels and mortality in type 2 diabetesChristel Joergensen, Mari-Anne Gall, Anne Schmedes, et al.
Diabetes Care|February 27, 2010
Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patientsStine Elkjaer Nielsen, Takeshi Sugaya, Peter Hovind, et al.
Kidney International|October 2, 2004
Progression of nephropathy in type 2 diabetic patientsKasper Rossing, Per K Christensen, Peter Hovind, et al.
Ugeskrift for Laeger|March 19, 2009
[Aliskiren combined with losartan in type 2-diabetes and nephropathy - secondary publication]Hans-Henrik Parving, Frederik Persson, Julia B Lewis, et al.
Nephron. Clinical Practice|December 17, 2010
Urinary neutrophil gelatinase-associated lipocalin and progression of diabetic nephropathy in type 1 diabetic patients in a four-year follow-up studyStine Elkjaer Nielsen, Henrik Post Hansen, Berit Ruud Jensen, et al.
Kidney International|January 29, 2011
Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathyStine E Nielsen, Steen Andersen, Dietmar Zdunek, et al.
British Journal of Clinical Pharmacology|April 16, 2015
The renal protective effect of angiotensin receptor blockers depends on intra-individual response variation in multiple risk markersBauke Schievink, Dick de Zeeuw, Hans-Henrik Parving, et al.
Diabetes Care|March 1, 2003
Comparative effects of Irbesartan on ambulatory and office blood pressure: a substudy of ambulatory blood pressure from the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria studyKasper Rossing, Per K Christensen, Steen Andersen, et al.
Kidney International. Supplement|March 9, 2005
Renoprotection with and without blood pressure reductionGozewijn Dirk Laverman, Steen Andersen, Peter Rossing, et al.
Pageof 26